Marty Tenenbaum to Speak at Precision Medicine World Conference on Jan 23

Cancer Commons founder Marty Tenenbaum, Ph.D., will speak at the upcoming Precision Medicine World Conference (PMWC) in Silicon Valley, which runs Jan 22–24. Marty, who founded Cancer Commons after his own battle with melanoma, will discuss the potential for artificial intelligence to help find better cancer treatments.

Read the synopsis of Marty’s presentation, entitled “How AI will Cure Cancer”:

From an AI perspective, finding effective treatments for cancer is a high-dimensional probabilistic planning, search, and optimization problem, characterized by many molecularly distinct cancer subtypes and potential drug combinations, and a dearth of high quality data connecting them to clinical responses. Many organizations are developing relevant AI-based applications, from decision support tools to treatment planning. We will describe a bold industry-wide initiative to integrate these capabilities for the immediate benefit of patients and physicians, and moderate an open discussion toward catalyzing an active AI-and-cancer community.

Marty’s talk takes place on Jan 23 at 4:45 pm. If you’d like to attend, register using this link for a 5% discount.